









Markets
/
Stocks
/
nasdaq-okyo
/

OKYO Pharma Ltd

OKYO

2.030USD

+0.160+8.56%

Close 12/19, 16:00（ET）Quotes delayed by 15 min

73.12MMarket Cap

LossP/E TTM



OKYO Pharma Ltd

2.030

+0.160+8.56%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of OKYO Pharma Ltd to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025H1

FY2024H2

FY2024H1

FY2023H2

FY2023H1

FY2022H2

FY2022H1

FY2021H2

FY2021H1

FY2020H2

FY2020H1

FY2019H2

FY2019H1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

96.23%-193.89K

11.36%-3.37M

-114.20%-5.14M

-39.72%-3.80M

-48.46%-2.40M

-362.89%-2.72M

-402.36%-1.62M

-286.29%-588.05K

45.29%-321.83K

74.76%-152.23K

2.28%-588.22K

---603.08K

---601.94K

Net income from continuing operations

50.20%-3.29M

-10.76%-7.67M

-75.56%-6.61M

-97.31%-6.93M

-157.12%-3.77M

-132.49%-3.51M

-112.04%-1.46M

-4421.12%-1.51M

32.34%-690.75K

101.72%34.95K

-8.57%-1.02M

---2.03M

---940.38K

Operating gains losses

-39.05%957.66

-10.04%1.73K

38.74%1.57K

50.00%1.93K

-87.21%1.13K

-76.24%1.28K

368.09%8.85K

56.90%5.40K

1364.45%1.89K

2506.67%3.44K

--129.13

--132.14

----

Other non-cash items

90.35%697.97K

330.49%3.15M

-14.44%366.68K

-22.55%731.40K

-6.67%428.54K

247.11%944.33K

16.33%459.18K

187.89%272.06K

-12.88%394.73K

-122.62%-309.53K

55.88%453.10K

--1.37M

--290.67K

Change in working capital

117.84%2.40M

-51.82%1.15M

17.69%1.10M

1629.36%2.39M

250.91%935.86K

-124.24%-156.36K

-2138.81%-620.15K

442.60%645.17K

-35.15%-27.70K

100.47%118.90K

-142.90%-20.50K

--59.31K

--47.78K

-Change in receivables

-154.68%-164.21K

257.63%160.54K

226.80%300.30K

107.56%44.89K

318.56%91.89K

-22302.24%-593.88K

-136.60%-42.04K

-98.49%2.67K

142.96%114.88K

363.32%176.67K

-2052.89%-267.38K

---67.09K

---12.42K

-Change in payables and accrued expense

132.94%2.04M

-15.54%1.46M

34.05%877.72K

316.13%1.72M

210.33%654.78K

-37.92%414.22K

-217.61%-593.50K

928.88%667.25K

-175.69%-186.87K

-163.68%-80.50K

310.14%246.88K

--126.41K

--60.19K

-Change in other current liabilities

191.15%69.84K

-168.67%-402.08K

-220.94%-76.62K

2412.80%585.51K

311.53%63.35K

193.86%23.30K

2283.86%15.39K

-209.22%-24.82K

---704.90

--22.73K

--0.00

----

Cash from non-recurring investing activities

Cash from operating activities

96.23%-193.89K

11.36%-3.37M

-114.20%-5.14M

-39.72%-3.80M

-48.46%-2.40M

-362.89%-2.72M

-402.36%-1.62M

-286.29%-588.05K

45.29%-321.83K

74.76%-152.23K

2.28%-588.22K

---603.08K

---601.94K

Investing cash flow

Net cash from continuing investing activities

----

-100.00%0.00

----

100.71%2.77K

--2.01K

-45.76%1.38K

-100.00%0.00

--2.54K

--1.13K

-100.00%0.00

--0.00

--802.34

----

Capital expenditures

----

-100.00%0.00

----

100.71%2.77K

--2.01K

-45.76%1.38K

-100.00%0.00

--2.54K

--1.13K

-100.00%0.00

--0.00

--802.34

----

Net cash flow from disposal of fixed assets

----

-100.00%0.00

----

100.71%2.77K

--2.01K

-45.76%1.38K

-100.00%0.00

--2.54K

--1.13K

-100.00%0.00

--0.00

--802.34

----

Net cash flow from other investing activities

----

92.24%-6.15K

----

---79.25K

----

Cash from non-current investing activities

Net cash flow from investing activities

----

100.00%0.00

----

-100.71%-2.77K

---2.01K

84.13%-1.38K

100.00%0.00

89.03%-8.70K

---1.13K

-9777.47%-79.25K

--0.00

---802.34

----

Financing cash flow

Cash flow from continuous financing activities

-85.36%443.33K

-62.47%2.34M

146.77%3.03M

572.56%6.22M

59.64%1.23M

2102.81%925.13K

-82.94%768.52K

-87.43%42.00K

1643.44%4.51M

--334.24K

--258.44K

----

Net cash flow from debt Issuance/repayment

--441.87K

----

17635.37%1.59M

100.00%0.00

-73.10%8.95K

-100.18%-8.04K

-28.11%33.27K

8692.73%4.37M

--46.28K

---50.85K

----

Net cash flow from common stock issuance/repurchase

-100.00%0.00

-44.72%2.34M

83.03%3.03M

--4.22M

--1.65M

--0.00

-100.00%0.00

-55.98%136.14K

--287.96K

--309.29K

----

Proceeds from stock option exercised by employees

----

--0.00

--8.10K

----

--0.00

----

Proceeds from issuance of warrants

----

-100.00%0.00

--916.18K

--776.56K

----

Net cash flow from other financing activities

--1.45K

----

--410.27K

---427.30K

----

--618.11

----

Net cash from non-recurrent financing activities

Net cash from financing activities

-85.36%443.33K

-62.47%2.34M

146.77%3.03M

572.56%6.22M

59.64%1.23M

2102.81%925.13K

-82.94%768.52K

-87.43%42.00K

1643.44%4.51M

--334.24K

--258.44K

----

Net cash flow

Beginning cash balance

-78.30%664.30K

60.54%1.63M

80.20%3.06M

-78.64%1.02M

-54.18%1.70M

14.50%4.75M

2500.67%3.71M

9900.43%4.15M

-61.67%142.59K

-95.78%41.51K

-76.50%372.04K

--984.24K

--1.58M

Current period cash flow changes

107.01%128.83K

-142.87%-1.04M

-56.34%-1.84M

234.36%2.42M

-38.57%-1.18M

-224.16%-1.80M

-120.28%-848.22K

-639.85%-554.75K

1368.33%4.18M

117.03%102.76K

45.25%-329.78K

---603.52K

---602.31K

Effect of exchange rate changes

-143.66%-120.61K

----

--276.24K

----

--367.94

---366.60

Ending cash balance

-35.22%793.12K

-82.70%593.72K

133.73%1.22M

16.13%3.43M

-81.69%523.79K

-17.84%2.95M

-33.88%2.86M

2392.64%3.60M

10136.41%4.33M

-62.11%144.27K

-95.69%42.25K

--380.72K

--980.67K

Free cash flow

----

11.43%-3.37M

----

-39.75%-3.81M

-48.59%-2.40M

-361.13%-2.72M

-400.61%-1.62M

-287.96%-590.60K

45.10%-322.95K

74.79%-152.23K

---588.22K

---603.89K

----

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

